Mangoceuticals Inc. recently completed two notable share transactions. On July 29, 2025, a holder of outstanding warrants exercised the option to purchase 198,000 shares of common stock at an exercise price of $1.50 per share, totaling $297,000. Additionally, as part of a Mutual Rescission and Release Agreement with Navy Wharf on July 30, 2025, Navy Wharf agreed to cancel 1,000,000 shares of Mangoceuticals' restricted common stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-011557), on August 04, 2025, and is solely responsible for the information contained therein.